DOCSLIB.ORG

Key Components of Breastfeeding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Key Components of Breastfeeding 6/8/2020 OVERVIEW • Economic benefits of breastfeeding • Maternal benefits of breastfeeding • Infant benefits of breastfeeding • Maternal risk factors • Infant risk factors BREASTFEEDING BENEFITS, RISKS, Presented by: Ashley Denker, MSN, • Contraindications for breastfeeding CONTRAINDICATIONS RNC-MNN, IBCLC THERE IS NO EQUAL SUBSTITUTE ECONOMIC BENEFITS “Human milk is species specific, and all substitute If 90% of U.S. mothers complied with the feeding preparations differ from it, making human recommendation to exclusively breastfeed for 6 milk uniquely superior for infant feeding.” AAP, 2012 months: •Savings of $13 billion annually •Decrease healthcare system costs by $2.45 billion •Eliminates formula costs of $4 to $10 per day (AAP, 2012; WHO, 2020) ECONOMIC BENEFITS MATERNAL BENEFITS Globally: • Psychological Benefits •Save the lives of 800,000 children each year • Postpartum Recovery •Save $300 billion • Health Benefits •Every $1 invested in breastfeeding generates $35 in economic returns (WHO, 2020) (LAWRENCE & LAWRENCE, 2016) 1 6/8/2020 MATERNAL BENEFITS MATERNAL BENEFITS Psychological: Postpartum Recovery: Reduced Health Risks of: •Maternal Hormones •Return to pre-pregnancy state •Breast cancer and ovarian cancer •Maternal Empowerment & quicker •Osteoporosis Fullfillment •Oxytocin release •Rheumatoid Arthritis •Increased Infant Interaction •Cardiovascular Disease •Decreased risk of postpartum •Type 2 Diabetes depression and anxiety (LAWRENCE & LAWRENCE, 2016) (LAWRENCE & LAWRENCE, 2016) MATERNAL BENEFITS INFANT BENEFITS •Species & Age Specific Breast & Ovarian Cancer: •Nutritional Advantages •Cumulative breastfeeding duration of > 12 months results in a 28% decrease •Decreased Comorbities •Each year of breastfeeding results in a 4.3% reduction in breast •Infection Prevention cancer •Immunologic Protection Type 2 Diabetes: •4-12% decreased risk in mothers without gestational diabetes •Allergy Prophylaxis diagnosis •Psycho/Social/Cognitive Benefits (AAP, 2012) •SIDS Prevention INFANT BENEFITS – SPECIFICITY INFANT BENEFITS – SPECIFICITY Species Specific: Gestational Age Specific: •Nutrients uniquely tailored to baby •Preterm milk contains higher levels of •Constantly changing protective factors including immunoglobulins, fatty acids, and cytokines. •Lower rates of NEC, sepsis, severe retinopathy, metabolic syndrome •Enhanced neurodevelopment (AAP, 2012; LAWRENCE & LAWRENCE, 2016; USBC, 2020) (AAP, 2012; LAWRENCE & LAWRENCE, 2016; USBC, 2020) 2 6/8/2020 INFANT BENEFITS - NUTRITIONAL INFANT BENEFITS - NUTRITIONAL •Highly, efficient bioavailability and utilization •Nutrient to nutrient •Contains cholesterol, DHA, & taurine essential for brain interaction growth and development •Ligands bind to micronutrients •Enzymes contribute to digestion •Iron almost completely absorbed compared with only •Lactoferrin binds to iron 10% of the iron in formula •Proteins •Healthy eating habits (LAWRENCE & LAWRENCE, 2016) (LAWRENCE & LAWRENCE, 2016; USBC, 2020) INFANT BENEFITS – COMORBITIES INFANT BENEFITS – COMORBITIES •Cardiovascular Disease •Obesity •Reduced risk of hypertension •15-30% reduction in adolescent and adult obesity if any •Decreased risk of atherosclerosis breastfeeding occurs •Lower LDL levels •Additional 4% reduction associated with each month of •Diabetes breastfeeding •30% reduction of type 1 diabetes mellitus after exclusively breastfeeding for 3 months •40% reduction of type 2 diabetes mellitus (AAP, 2012; LAWRENCE & LAWRENCE, 2016) (AAP, 2012; LAWRENCE & LAWRENCE, 2016) INFANT BENEFITS – INFECTION PROTECTION INFANT BENEFITS – IMMUNOLOGIC PROTECTION Leukocytes, antibodies Decreased risk of: Decreased risk of: and additional •Respiratory Tract Infections •Leukemia antimicrobial factors •RSV Bronchiolitis •Celiac Disease protect against infection •Otitis Media •Inflammatory Bowel Syndrome •Gastrointestinal Infections •Crohn’s Disease (AAP, 2012; LAWRENCE & LAWRENCE, 2016) (AAP, 2012; LAWRENCE & LAWRENCE, 2016) 3 6/8/2020 INFANT BENEFITS – ALLERGY PROPHYLAXIS INFANT BENEFITS – PSYCHO/SOCIAL/COGNITIVE •Decreased incidence of eczema, atopic dermatitis, and •More mature, secure, assertive, and progress farther on the asthma developmental scale •Exclusive breastfeeding for 3-4 months results in •Greater rapid visual acuity development • 27% reduction in risk in low-risk infants •Higher intelligence test scores, teacher ratings and educational • 42% reduction in infants with positive family history achievements •Enhanced lung volume and function •Decreases risk of abuse and neglect (AAP, 2012; LAWRENCE & LAWRENCE, 2016) (AAP, 2012; LAWRENCE & LAWRENCE, 2016) INFANT BENEFITS – SIDS RISK FACTORS “21% of the US infant “Prior to discharge, mortality has been anticipation of breastfeeding problems attributed, in part, to the should be assessed based increased rate of SIDS in on maternal and infant risk infants who were never factors.” breastfed.” •Risk factors have a dose effect! (AMERICAN ACADEMY OF PEDIATRICS, 2012; USBC 2020) (EVANS ET AL., 2014) MATERNAL RISK FACTORS – MEDICAL HISTORY MATERNAL MEDICATION USE •Most mediations are safe for use during breastfeeding •Extremes of age •Healthcare providers should consult lactation resources •Maternal Obesity for individual medication information • U.S. National Library of Medicine (Formerly LactMed) •Maternal medication use • Infantrisk.com (Dr. Thomas Hale) •Inappropriate advice may lead to mothers discontinuing breastfeeding unnecessarily •Weigh the risks of drug exposure through milk and the risk of interrupting or stopping lactation (EVANS ET AL., 2014; LAUWERS & SWISHER, 2016; LAWRENCE & LAWRENCE, 2016) (AAP, 2013; CDC, 2019) 4 6/8/2020 MEDICATION CONTRAINDICATIONS MATERNAL RISK FACTORS – MEDICAL HISTORY •Live attenuated vaccines contraindicated Significant medical problems: •Radiopharmaceuticals contraindicated • Untreated hypothyroidism, pituitary problems (Sheehan’s syndrome), diabetes, hypertension, cystic fibrosis and PCOS •Nuclear Regulatory Commission •Acute medical conditions •Lithium is no longer contraindicated Psychosocial problems: • Sleep deprivation, anxiety, depression, PTSD, and lack of social support for breastfeeding Maternal history of abuse (CDC, 2019) (EVANS ET AL., 2014; LAUWERS & SWISHER, 2016; LAWRENCE & LAWRENCE, 2016) MATERNAL RISK FACTORS - PSYCHOSOCIAL MATERNAL RISK FACTORS – REPRODUCTIVE HISTORY Depression and Anxiety: •Primiparity •Decrease oxytocin •Infertility Breastfeeding challenges • •Conception by assisted reproductive technology •Bonding attachment Breastfeeding problems •Early cessation of exclusive breastfeeding • •Early weaning •Low milk supply •Antenatal administration of betamethasone (LAUWERS & SWISHER, 2016) LAUWERS & SWISHER, 2016; LAWRENCE & LAWRENCE, 2016) MATERNAL RISK FACTORS – A & P MATERNAL RISK FACTORS – LDRP EXPERIENCE • Previous breast surgery – Always ask! • Prolonged labor • Previous breast abscess • Long induction or augmentation of labor • Lack of noticeable breast enlargement during puberty or pregnancy • Use of medication during labor • Flat, inverted, or very large nipples • Unplanned c-section • Variation in breast appearance (marked asymmetry, hypoplastic or tubular) • Postpartum Complications • Hemorrhage • Hypertension, preeclampsia, eclampsia • Infection (EVANS ET AL., 2014; WILSON-CLAY & HOOVER, 2005) (EVANS ET AL., 2014) 5 6/8/2020 MATERNAL FACTORS – FINANCIAL NEEDS MATERNAL FACTORS – PLANS & INTENTIONS Breastfeeding is considered “well established” after 6 weeks Does she •Does she plan to use medication during labor? intend or •Does she intend to breast and bottle feed (with PBM or formula) need to return before 6 weeks of age? •Does she plan on using pacifiers and/or artificial nipples/teats to school or before 6 weeks of age? work? •Does she plan on using hormonal contraception before 6 weeks? (EVANS ET AL., 2014) MATERNAL RISK FACTORS – RED FLAGS INFANT RISK FACTORS •No signs of milk “coming in” by 72 hours postpartum • Medical •Mother is unable to hand express milk • Anatomy & Physiology •Need for breastfeeding aid or appliances at the time of discharge • LDRP Experience •Requires special feeding plan • Environmental (EVANS ET AL., 2014; LAUWERS & SWISHER, 2016; LAWRENCE & LAWRENCE, 2016) (USBC, 2020) INFANT RISK FACTORS – MEDICAL/A&P INFANT RISK FACTORS – MEDICAL/A&P • Low birth weight, SGA, IUGR Oral anatomic Neurologic problems: • Premature or late preterm abnormalities: •Genetic disorders •Cleft lip and/or palate Hypertonia • LGA • •Macroglossia •Hypotonia • Postterm > 41 weeks •Micrognathia (mandibular • Multiples hypoplasia) • Difficulty latching to one or both breasts •Ankyloglossia (tongue tie) • Ineffective or un-sustained suckling • Persistent sleepiness (EVANS ET AL., 2014; LAUWERS & SWISHER, 2016; LAWRENCE & LAWRENCE, 2016) (EVANS ET AL., 2014) 6 6/8/2020 INFANT RISK FACTORS – MEDICAL/A&P INFANT RISK FACTORS - LDRP Medical problems: Excessive weight loss: • Stressful delivery •Hypoglycemia •> 7-10% of birth weight in the • Birth trauma Infection first 48 hours of life • • Born after long epidural •Jaundice Less than 2 hours of skin to skin •Respiratory distress • with mother immediately after •Hypothermia birth •Prematurity (EVANS ET AL., 2014) (USBC, 2020) INFANT RISK FACTORS - ENVIRONMENTAL CONTRAINDICATIONS TO BF - MATERNAL •Breast pump deficiency NICU: 3 Categories: •Formula Supplementation •Maternal infant separation • Should NOT breastfeed or feed expressed breastmilk •Lack of established, effective •Medical interventions • Should temporarily NOT breastfeed and should NOT breastfeeding
Load more

Recommended publications
  • Opinion of Trustees Resolution of Dispute Case No
    Opinion of Trustees Resolution of Dispute Case No. 88-122 Page 1 _____________________________________________________________________________ OPINION OF TRUSTEES _____________________________________________________________________________ In Re Complainant: Employee Respondent: Employer ROD Case No: 88-122 - October 3, 1989 Board of Trustees: Joseph P. Connors, Sr., Chairman; Paul R. Dean, Trustee; William Miller, Trustee; Donald E. Pierce, Jr., Trustee; Thomas H. Saggau, Trustee. Pursuant to Article IX of the United Mine Workers of America ("UMWA") 1950 Benefit Plan and Trust, and under the authority of an exemption granted by the United States Department of Labor, the Trustees have reviewed the facts and circumstances of this dispute concerning the provision of health benefits coverage for orthodontic treatment under the terms of the Employer Benefit Plan. Background Facts An oral surgeon states that the Employee's daughter began experiencing pain and popping in the right temporomandibular joint after being hit in the area of the right mandible during a fight in March 1985. She was treated by a physical therapist and had splint therapy to correct her temporomandibular joint problems for about six months. In August 1985, the Employee's daughter suffered a second injury to the right side of the head. She continued having pain and popping in the right temporomandibular joint, and surgery, an arthroplasty of the joint, was performed in December 1986. The Employer provided coverage for the physical therapy, the splint therapy and the surgery to correct her temporomandibular joint problems. In March 1988, an oral surgeon recommended orthodontic treatment to alleviate all of the Employee's daughter's symptoms. The Employee's daughter was examined by an orthodontist on May 10, 1988; he noted that she had reciprocal clicking in both temporomandibular joints, lack of proper chewing motion, limited mobility of the mandible, frequent headaches, and tenderness in the right jaw joint.
    [Show full text]
  • AN OVERVIEW of VESICOBULLOUS CONDITIONS AFFECTING the ORAL MUCOSA EMMA HAYES, STEPHEN J CHALLACOMBE Prim Dent J
    AN OVERVIEW OF VESICOBULLOUS CONDITIONS AFFECTING THE ORAL MUCOSA EMMA HAYES, STEPHEN J CHALLACOMBE Prim Dent J. 2016; 5(1):46-50 in the palate, buccal mucosa and labial ABSTRACT mucosa there is an underlying submucosa. The epithelium is formed of several layers, Vesicobullous diseases are characterised by the presence of vesicles or bullae at the deepest being the layer of progenitor varying locations in the mucosa. The most common occurring in the oral cavity cells forming the stratum germinativum, are mucous membrane pemphigoid (MMP) and pemphigus vulgaris (PV). Both adjacent to the lamina propria. are autoimmune diseases with a peak age onset of over 60 years and females Keratinocytes increase in size and flatten are more commonly affected than men. This paper reviews the structure of the as they move through the stratum spinosum oral mucosa, with specific reference to the basement membrane zone, as well and stratum granulosum to the stratum as bullous conditions affecting the mucosa, including PV and pemphigoid, their corneum (in keratinized mucosa) where the aetiology, clinical presentation, and management. desmosomes, which hold the cells together, weaken – therefore allowing normal Learning outcomes desquamation. • Understand the common presentation of vesicobullous diseases. • Appreciate the role of investigations in diagnosis and its interpretation. In addition to desmosomes, epithelial • Appreciate the roles of both primary and secondary care in patient management. cell-cell contact occurs via occludens (tight junctions), and nexus junctions (gap junctions), with each having a complex structure. Desmosomes are small adhesion Introduction proteins (0.2µm) 1 which guarantee the Vesicobullous diseases are characterised by integrity of the epidermis by linking the the presence of vesicles or bullae at varying intermediate filaments within cells to the locations in the mucosa.
    [Show full text]
  • Albany Med Conditions and Treatments
    Albany Med Conditions Revised 3/28/2018 and Treatments - Pediatric Pediatric Allergy and Immunology Conditions Treated Services Offered Visit Web Page Allergic rhinitis Allergen immunotherapy Anaphylaxis Bee sting testing Asthma Drug allergy testing Bee/venom sensitivity Drug desensitization Chronic sinusitis Environmental allergen skin testing Contact dermatitis Exhaled nitric oxide measurement Drug allergies Food skin testing Eczema Immunoglobulin therapy management Eosinophilic esophagitis Latex skin testing Food allergies Local anesthetic skin testing Non-HIV immune deficiency disorders Nasal endoscopy Urticaria/angioedema Newborn immune screening evaluation Oral food and drug challenges Other specialty drug testing Patch testing Penicillin skin testing Pulmonary function testing Pediatric Bariatric Surgery Conditions Treated Services Offered Visit Web Page Diabetes Gastric restrictive procedures Heart disease risk Laparoscopic surgery Hypertension Malabsorptive procedures Restrictions in physical activities, such as walking Open surgery Sleep apnea Pre-assesment Pediatric Cardiothoracic Surgery Conditions Treated Services Offered Visit Web Page Aortic valve stenosis Atrial septal defect repair Atrial septal defect (ASD Cardiac catheterization Cardiomyopathies Coarctation of the aorta repair Coarctation of the aorta Congenital heart surgery Congenital obstructed vessels and valves Fetal echocardiography Fetal dysrhythmias Hypoplastic left heart repair Patent ductus arteriosus Patent ductus arteriosus ligation Pulmonary artery stenosis
    [Show full text]
  • Tongue-Ties and Sleep Issues (And More!) by Richard Baxter, DMD, MS, DABLS
    LASERfocus Tongue-Ties and Sleep Issues (and More!) by Richard Baxter, DMD, MS, DABLS tongue-tie is a thick, tight, or short string of tissue under the tongue that restricts the tongue’s movement and causes a A functional issue. Collectively, tongue-ties and lip-ties are referred to as tethered oral tissues. They are often misdiagnosed or misunderstood, and they are quite common. The frequency with which anterior tongue-ties occur is estimated to range from 4-10% in the general population, and posterior tongue-ties have been reported in as many as 32.5% of infants in a recent study.1 flat palate, the baby is born with a high arched For a tight piece of tissue to qualify as a tongue-tie, it must have or “bubble” palate which leaves less room for a functional impact on nursing, speech, feeding, or sleep. Infant the base of the nose and less volume available problems arising from tongue-ties include painful and prolonged for the nasal cavity. Tongue-ties also lead to several of the main causes of breastfeeding nursing episodes, poor stimulation of maternal milk production, cessation, including nipple pain, trouble reflux, slow weight gain, gassiness, and a host of other issues for latching, and concerns that the baby is not mom and/or baby. As babies advance to eating solids, tongue- getting enough milk.3 It has been demon- strated in many controlled studies that releas- ties can lead to gagging, refusing food, spitting out food, and ing tongue-ties, whether classic near-the-tip picky eating.
    [Show full text]
  • Bruce R. Maddern M.D., P.A. Post Frenuloplasty (Procedure to Resolve
    Bruce R. Maddern M.D., P.A. Post Frenuloplasty (procedure to resolve “tongue-tie”) Instructions Ankyloglossia (“tongue-tie”) is a condition present from birth in which movement of the tongue tip is restricted due to an unusually short and/or thick frenulum. A frenulum is a band of tissue that anchors the tongue to the floor of the mouth behind the teeth. When the frenulum is too short or tight, the tongue tip is unable to move freely. This may result in difficulty with early bottle or breast-feeding or future speech articulation. The most common reason to perform frenuloplasty in a newborn is difficulty with feeding or latching. It is often possible to perform the procedure in office for infants under 6 months of age with a local anesthetic. The baby can feed immediately following the procedure. In toddlers it may be necessary to perform a frenuloplasty because of speech articulation issues. If a frenuloplasty is required for this age group the procedure occurs in the operating room under a brief general anesthesia. The entire procedure usually is complete with in 15 minutes. Speech therapy is necessary to ensure improved mobility of the tongue for older children. General risks from frenuloplasty include bleeding, pain, scarring, and infection. General Information • The patient may resume normal activity following surgery, including normal feeding schedule (bottle, breast, or soft food). • The patient may return to daycare the next day. • Some discomfort or tongue swelling is expected following this procedure. You may treat your child with Tylenol or Ibuprofen. • For infants the normal movements of the tongue during breast of bottle feeding is adequate stretching • Ice pops are a good way to numb the area.
    [Show full text]
  • Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-Tie Comparative Effectiveness Review Number 149
    Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00009-I Prepared by: Vanderbilt Evidence-based Practice Center Nashville, TN Investigators: David O. Francis, M.D., M.S. Sivakumar Chinnadurai, M.D., M.P.H. Anna Morad, M.D. Richard A. Epstein, Ph.D., M.P.H. Sahar Kohanim, M.D. Shanthi Krishnaswami, M.B.B.S., M.P.H. Nila A. Sathe, M.A., M.L.I.S. Melissa L. McPheeters, Ph.D., M.P.H. AHRQ Publication No. 15-EHC011-EF May 2015 This report is based on research conducted by the Vanderbilt Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2012-00009-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment.
    [Show full text]
  • Ankyloglossia and Oral Frena Consensus Statement
    Acknowledgments The Australian Dental Association, in association with an expert multidisciplinary panel of health professionals has developed the Ankyloglossia and Oral Frena Consensus Statement to provide evidence-based recommendations to guide best practice in caring for individuals with short, tight labial and lingual frena and ankyloglossia. Working group members are acknowledged below. Expert working group members Chair Dr Mihiri Silva (Paediatric Dentist) BDSc, MDSc, DCD (Paediatric Dentistry), PhD Australasian Academy of Paediatric Dentistry Dr Kareen Mekertichian (Paediatric Dentist) (AAPD) BDS, MDSc, FRACDS, MRACDS (Paed Dent), FICD, FPFA Australian Chiropractors Association (ACA) Dr Russell Mottram (Chiropractor) B.App.Sc (Chiropractic) Australian College of Midwives (ACM) Ms Lois Wattis (Clinical Midwife and IBCLC) BNurs, PGradDipMidwifery, FACM, IBCLC Australian College of Midwives (ACM) Ms Michelle Simmons (Clinical Midwife Consultant, Westmead) MNurs, IBCLC Australian Dental Association (ADA) Prof Laurence Walsh (Specialist in Special Needs Dentistry) BDSc, PhD, DDSc, GCEd, FRACDS, FFOP (RCPA) Australian Dental Association (ADA) Dr Philippa Sawyer (Paediatric Dentist) BDS (USyd), MA (Sports Studies) (UTS), GradCertPedDent (NYU) PGCertHEd (MQU), Master of Early Childhood (MQU), FICD, FAAPD, FIADT Diplomate, American Board of Pediatric Dentistry Australian Dental Association (ADA) Ms Eithne Irving Deputy CEO & Policy General Manager RN, Grad Dip Neuroscience, MBA Australian Dental Association (ADA) Dr Mikaela Chinotti (Dentist) Oral Health Promoter BDS, MPH Australian Dental & Oral Health Therapists' Ms Nicole Stormon (Oral Health Therapist) Association (ADOHTA) BOH, AFHEA Australian and New Zealand Association of Oral and A/Prof David Sherring (Oral and Maxillofacial Surgeon) Maxillofacial Surgeons (ANZAOMS) MBBS, BDS, DClinDent, FRACDS (OMS) President ANZAOMS (2017-2019) Lactation Consultants of Australia & New Zealand Ms Heather Gale (IBCLC, Registered Nurse and Midwife) (LCANZ) IBCLC/RN/RM/Post grad.
    [Show full text]
  • Ankyloglossia and Other Oral Ties
    Ankyloglossia and Other Oral Ties a b, Jonathan Walsh, MD , Margo McKenna Benoit, MD * KEYWORDS Ankyloglossia Tongue-tie Lip-tie Frenulectomy Frenotomy KEY POINTS Ankyloglossia, or tongue-tie, has become a topic of great interest and some controversy over the past 20 to 30 years, as rates of breastfeeding initiation have increased. Tongue-tie can result in various degrees of difficulty with breastfeeding, oral hygiene, speech, and dentition. Diagnosis must include a functional assessment of tongue mobility, in addition to the physical appearance of the frenulum. Procedures to address ankyloglossia and other oral ties are commonly accepted as safe; however, serious complications such as severe bleeding, infection, and worsening glos- soptosis have been reported. There is little evidence to date supporting surgical intervention for maxillary, mandibular, or other oral ties. INTRODUCTION The lingual frenulum is formed during the fourth week of gestation as the 2 lateral lingual swellings move medially to fuse with the tuberculum impar, forming the ante- rior two-thirds of the tongue. The tongue then separates from the floor of mouth to form the lingual sulcus. Failure of release results in varying degrees of ankyloglossia, or tongue-tie, in which a fibrous band in the midline tethers the tongue to the alveolar ridge or floor of mouth. Ankyloglossia can be asymptomatic or may have a wide array of consequences, including difficulty with breastfeeding, oral hygiene, dental devel- opment, speech, and other social factors. Treatment often involves division of the band to provide better tongue mobility. Although this is generally accepted to be a minor and safe procedure, there is considerable debate about when and how to intervene.
    [Show full text]
  • Newborn Handbook
    Pediatric Residency Newborn Handbook 2020-2021 1 Table of Contents Topic Page Contact Information 3 Routine Newborn Care 4 Discharge Talk Guidelines 5-7 AAP Recommendations for Healthy Term Newborn Discharge Criteria 8-9 Basic management of maternal labs/risk factors and Medication Refusal 10-11 Routine Vitamin K Prophylaxis 12 Hep B Vaccine Information and Management of Maternal Hepatitis B Status 13 Routine Erythromycin Prophylaxis for Ophthalmia Neonatorum 14 Hearing Screen 15 CCHD Screening 16 Michigan Newborn Screening 17 Breast Feeding 18-19 Infant feeding policy (donor breast milk) 20 Ankyloglossia and Frenotomy 21 Circumcision 22 Car Seat Safety 23-24 Nursery Protocols 25 Locating Policies, Procedures & Protocols 25 NRP (Neonatal Resuscitation Protocol), APGAR Scoring, MR. SOPA 26 Indirect Hyperbilirubinemia 27-30 Hypoglycemia Algorithm 31-32 Hypoglycemia Treatment, SGA & LGA cutoffs, and Pounds to Kilogram Conversion 33 Chorioamnionitis protocol and antibiotic duration, GBS Algorithm 34-35 Temperature Regulation 36-38 On-Call Problems & a note about SBARs 39 Respiratory/Cardiovascular Respiratory Distress 40-41 Cyanosis 42 Heart Murmurs, Cardiac Exam, and CHD 43 FEN/GI/Endo: Newborn Fluid Management and Weight Specific Guidelines for Feeding 44 Bilious Vomiting 45-46 When You’re Asked About the Appearance of Baby Poop 47 Bloody Stool 48 No stool in 48 hours of life and No void in 30 hours of life 49 Maternal Graves’ Disease 50 Renal Management of Antenatal Hydronephrosis 51 HEENT/Neuro Skull Sutures & Fontanels / Extracerebral Fluid Collections/Subgaleal Hemorrhage 52-53 Infant Fall 54 Oral-facial clefts 55-56 Neonatal Seizures 57 Neonatal Abstinence Syndrome 58-60 Infectious Disease Rubella, CMV, HIV 61 Syphillis 62-63 Toxoplasmosis, HSV 64 Recommended HSV management 64-67 Hepatitis C, Varicella 67 Assessing Gestational Age and the Ballard Score 68 Selected Lab Evaluation 69 Transferring to NICU 70 2 Contact Information Resident ASCOM: 76087.
    [Show full text]
  • Assessment of Posterior Tongue Mobility Using Lingual‐Palatal Suction
    Received: 18 November 2020 | Accepted: 21 December 2020 DOI: 10.1111/joor.13144 ORIGINAL ARTICLE Assessment of posterior tongue mobility using lingual- palatal suction: Progress towards a functional definition of ankyloglossia Soroush Zaghi1 | Shayan Shamtoob1 | Cynthia Peterson1 | Loree Christianson1 | Sanda Valcu-Pinkerton1 | Zahra Peeran1,2 | Brigitte Fung3 | Daniel Kwok-keung Ng4 | Triin Jagomagi5 | Nicole Archambault6 | Bridget O’Connor7 | Kathy Winslow8 | Miche’ Lano9 | Janine Murdock9 | Lenore Morrissey10 | Audrey Yoon11 1The Breathe Institute, Los Angeles, CA, USA Abstract 2Happy Kids Dental Planet, Agoura Hills, Background: A functional definition of ankyloglossia has been based on assessment CA, USA of tongue mobility using the tongue range of motion ratio (TRMR) with the tongue 3Kwong Wah Hospital, Hong Kong, Hong Kong tip extended towards the incisive papilla (TIP). Whereas this measurement has been 4Hong Kong Sanatorium & Hospital, Hong helpful in assessing for variations in the mobility of the anterior one-third of the Kong, Hong Kong tongue (tongue tip and apex), it may be insufficient to adequately assess the mobil- 5Institute of Dentistry and Unimed United ity of the posterior two-thirds body of the tongue. A commonly used modification is Clinics, University of Tartu, Tartu, Estonia 6Minds in Motion, Santa Monica, CA, USA to assess TRMR while the tongue is held in suction against the roof of the mouth in 7O’Connor Dental Health, Cork, Ireland lingual-palatal suction (LPS). 8Independent Researcher, Half Moon Bay, Objective: This study aims to explore the utility and normative values of TRMR-LPS CA, USA as an adjunct to functional assessment of tongue mobility using TRMR-TIP. 9South County Pediatric Speech, Mission Viejo, CA, USA Study Design: Cross-sectional cohort study of 611 subjects (ages: 3-83 years) from 10Be Well Collaborative Care, Huntington the general population.
    [Show full text]
  • Various Discrepancies During Development of Tongue
    Asian Pac. J. Health Sci., 2016; 3(1):156-160 e-ISSN: 2349-0659, p-ISSN: 2350-0964 ____________________________________________________________________________________________________________________________________________ Document heading doi: 10.21276/apjhs.2016.3.1.25 Various discrepancies during development of tongue Krishan Kumar Tyagi1*, Manoj Kumar Upadhyay2, Dilpreet Singh Grewal3 , Khushboo Singh4 Debiprasad Ghatak5,Vikas Sharma6 1 Department of Oral Pathology and Microbiology, M.B. Kedia Dental College, Birgunj, Nepal 2 Department of Conservative Dentistry, M.B. Kedia Dental College, Birgunj, Nepal 3 Department of Prosthodontics, Genesis Institute of Dental Sciences And Research, Ferozpur 4 Department of Community Dentistry, M.B. Kedia Dental College, Birgunj, Nepal 5 Department of Oral Surgery, D.J College Of Dental Sciences & Research, Modinagar, India 6 Department of Oral Pathology and Microbiology, D.J College of Dental Sciences & Research, Modinagar, India ABSTRACT The tongue has a rich nerve supply and can detect not only the usual sensation of touch, pressure, heat and cold but also the special sensation of taste. This well developed sensory capability may be considered as a protective feature as it permits the tongue to ‘review’ substances before they pass into gastro intestinal tract. The tongue is important muscular organ which can also help in diagnosing various systemic diseases as many primary as well as secondary manifestation of various diseases can be seen on tongue. Changes of the tongue are sometimes diagnostically significant. In scarlet fever the atrophy of the lingual mucosa causes the peculiar redness of the strawberry tongue. Systemic disease such as pernicious anemia and vitamin deficiencies, especially vitamin B-complex deficiency, lead to characteristic changes such as magenta tongue and beefy red tongue.
    [Show full text]
  • Current Update on Mucous Membrane Pemphigoid
    Biomedical & Pharmacology Journal Vol. 10(4), 1787-1791 (2017) Current Update On Mucous Membrane Pemphigoid SHAMIMUL HASAN1, JOGENDER JANGRA2 and PRIYADARSHINI CHOUDHARY3 1Department of Oral Medicine and Radiology, Faculty of Dentistry, Jamia Millia Islamia, New Delhi, India. 2Department of Oral and Maxillofacial Surgery,Government Dental College, Post Graduate Institute of Medical Sciences, Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak, Haryana, India. 3Department of Oral Medicine and Radiology, Kalinga Institute of Dental Sciences, KIIT University, Bhubaneswar, Odisha, India. *Correspodding author E-mail: [email protected] http://dx.doi.org/10.13005/bpj/1293 (Received: November 28, 2017; accepted: December 11, 2017) ABSTRACT Mucous membrane pemphigoid is a rare mucocutaneous disorder that has a predilection for the mucous membranes. Oral cavity is the chief site of involvement and desquamative gingivitis is the main presenting manifestation. Other mucous membranes like ocular, nasal, tracheal, laryngeal, pharyngeal and genital mucosa may also be affected. The disorder affects females in the middle age group. Histopathological and immunofluorescent features are highly diagnostic for the disease. Steroids are the mainstay of treatment, along with other immunosuppressive agents. This paper aims to present a recent update on mucous membrane pemphigoid taking in account its etio-pathogenesis, clinical and oral features, diagnostic aids and treatment protocols. Keywords: Mucous membrane pemphigoid, Desquamative gingivitis,
    [Show full text]